𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies

✍ Scribed by Vilma Oliveira Frick; Claudia Rubie; Pirus Ghadjar; Sabrina K. Faust; Mathias Wagner; Stefan Gräber; Martin K. Schilling

Book ID
107693876
Publisher
S. Karger AG
Year
2010
Tongue
English
Weight
409 KB
Volume
32
Category
Article
ISSN
1010-4283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dysregulated expression of CXCR4/CXCL12
Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus
✍ Andrew Wang; Philippe Guilpain; Benjamin F. Chong; Sandrine Chouzenoux; Loïc Gui 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

## Abstract ## Objective CXCR4 is a chemokine with multiple effects on the immune system. In murine lupus models, we demonstrated that monocytes, neutrophils, and B cells overexpressed CXCR4 and that its ligand, CXCL12, was up‐regulated in diseased kidneys. We undertook this study to determine whe

Expression of CXCR4 and CXCL12 (SDF-1) i
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo
✍ Yan-Xi Sun; Jingcheng Wang; Charles E. Shelburne; Dennis E. Lopatin; Arul M. Chi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

## Abstract Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The identification of molecules associated with aggressive phenotypes will help to define PCa subsets and will ultimately lead to better treatment strategies. The chemokine stromal‐derived fa